From: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
Characteristic | Number of patients | |
---|---|---|
Gender | Â | |
 | male | 14 |
 | female | 4 |
Median age, years | 57.9 | |
Age range, years | 45.1–80.6 | |
Tumor site | Â | |
 | Larynx | 5 |
 | Oropharynx | 3 |
 | Mouth floor | 2 |
 | Tongue | 2 |
 | Esophagus | 1 |
 | Hypopharynx | 1 |
 | Maxilla | 1 |
 | Nasopharynx | 1 |
 | Sinuses | 1 |
 | Soft palate | 1 |
T-Stage | Â | |
 | I | 4 |
 | II | 2 |
 | III | 6 |
 | IV | 6 |
N-Stage | Â | |
 | N0 | 4 |
 | N1 | 4 |
 | N2 | 10 |
M-Stage | Â | |
 | M0 | 16 |
 | M1 | 2 |
Concomitant therapy (in addition to radiotherapy) | Â | |
 |   5-FU + MMC | 12 (patient 3, 5–7, 9–13, 15–17) |
 |   MMC | 3 (patient 1, 14, 18) |
 |   Cisplatin | 1 (patient 8) |
 |   Cetuximab | 1 (patient 4) |
 |   none | 1 (patient 2) |
Acute Toxicity | Â | |
 | severe | 11 |
 | moderate | 5 |
 | n.a. | 2 |